Physician profile
Steve Antoine
NPI 1255776456
$65,150.38
in general payments reported to CMS, 2019-2025
10 companies · $23K in 2025
The $23K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $720 · 2020: $20K · 2021: $773 · 2022: $2,249 · 2023: $7,714 · 2024: $11K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Food and Beverage: $11K · Travel and Lodging: $6,755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,600.00 |
| Food and Beverage | $10,934.77 |
| Travel and Lodging | $6,754.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $35,558.41 | 2022-2025 | Barostim Neo System |
| Medtronic Vascular, INC. | $20,628.72 | 2019-2020 | |
| Abbott Laboratories | $6,712.89 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Impulse Dynamics (USA) INC. | $1,049.32 | 2022-2025 | Optimizer, Optimizer |
| Abiomed | $709.09 | 2022-2025 | Impella |
| Pfizer INC. | $202.23 | 2019 | |
| Cardiva Medical, INC. | $110.96 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic, INC. | $87.34 | 2021 | |
| Merck Sharp & Dohme LLC | $83.36 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Antoine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.